To evaluate whether intravenous Adenosine would replace the need for inhaled nitric oxide (iNO) in the management of Persistent Pulmonary Hypertension of the Newborn (PPHN)
Completed
- Conditions
- eonatal Diseases: Persistant pulmonary hypertensionNeonatal DiseasesOther pulmonary heart diseases
- Registration Number
- ISRCTN51768118
- Lead Sponsor
- Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 9
Inclusion Criteria
Neonates with PPHN requiring mechanical ventilation and inhaled nitric oxide at 20 parts per million
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Whether Adenosine can replace or supplement the use of iNO in the treatment of PPHN.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration